Bruker Corp BRKR

$61.36 +0.74 (1.22%)

Valuation

Market cap
9,258,008,000
Revenue TTM
$3,436,500,000
Net income TTM
$-8,600,000
P/E (trailing)
31.58
P/E (forward)
28.88
Profit margin
-0.25%
Debt to equity
0.74

Trading

Volume
1,875,300
Avg volume
2,472,864
Day's range
$60.03 – $62.22
Shares out
152,722,000
Stochastic %K
38%
Beta
1.26
Analysts
Moderate Buy
Price target
$68.15

Price

Company profile

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle s...

Show more

Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.

Industry
Medical Devices
Sector
Healthcare
Phone
978 663 3660
Website
https://www.bruker.com
Address
40 Manning Road, Billerica, United States

Latest news

Stocktwits

Bates333 Nov 16, 8:19 PM
$BRKR they’ll end up dumping this unfortunately
0 replies
cabanarock Nov 14, 1:49 AM
$BRKR I like how $BRKR Bruker is up when ai stocks down. I think I should open a position and sell some ai
0 replies
GTA_Terminal Nov 9, 2:08 PM
Dark pool check on $BRKR: what traded off the exchanges in the latest session. That came on a day the stock jumped hard, so the question is whether big holders were chasing it or selling into it. Read the full article for the full details: https://globaltradersacademy.com/articles/bruker-brkr-technical-levels-options-flow-dark-pools-line-up-above-59-01?utm_source=stocktwits&utm_medium=social
0 replies
shoc24 Nov 4, 3:04 PM
$BRKR reported earnings before the open today. Adjusted EPS beat estimates: $0.56 vs. $0.42 expected, according to Stock Meadow.
0 replies
EarningsInsider Nov 4, 2:46 PM
https://www.marketbeat.com/earnings/reports/2026-11-4-bruker-co-stock/ $BRKR Bruker Earnings Transcript
0 replies
DekmarTrades Nov 4, 12:09 PM
BRUKER $BRKR Q3’26 EARNINGS HIGHLIGHTS 🔹 Revenue: $874.0M (Est. $869M) 🟢; +1.6% YoY 🔹 Adj. EPS: $0.56 (Est. $0.42) 🟢; +24.4% YoY 🔹 Non-GAAP Oper Income: $142.6M (Est. $114M) 🟢 FY26 Guide: 🔹 Revenue: $3.52B-$3.56B (Est. $3.56B) 🟡 🔹 Adj. EPS: $2.10-$2.15 (Est. $2.12) 🟡 🔹 Adj. EPS Growth: +15% to +17% (Est. +15.8%) 🟡 🔹 Organic Revenue Growth: +1% to +2% Segment Net Revenue: 🔹 BSI: $793.9M; +0.8% YoY 🔹 BEST: $82.1M; +11.2% YoY Other Q3 Metrics: 🔹 Organic Revenue Growth: +0.7% 🔹 Non-GAAP Operating Margin: 16.3%; +400 bps YoY 🔹 Free Cash Flow: $96.7M Key Updates: 🔹 Goodwill Impairment: $174.5M non-cash charge Comments: 🔸 “In the third quarter, we achieved very significant margin expansion and non-GAAP EPS growth, driven by our focus on cost discipline and execution.”
0 replies
StocktwitsEarnings Nov 4, 12:09 PM
$BRKR Q3 '26 Earnings Results & Recap • Reported GAAP EPS of $0.56 up 24.44% YoY • Reported revenue of $874M up 1.57% YoY • Bruker expects FY26 revenues of $3.52B, organic revenue growth of 1% to 2%, and non-GAAP EPS of $2.10 to $2.15, reconfirming prior organic revenue growth and EPS guidance.
0 replies
Merlintrader Nov 4, 10:26 AM
$BRKR reports Q3 earnings today before the open. Consensus: EPS $0.42 (vs $0.45 a year ago), revenue $865M. Call 8:30 AM ET: https://ir.bruker.com/events-and-presentations/event-details/2026/Bruker-Corporation-Q3-2026-Earnings-Webcast/default.aspx Explore the chart, tested levels and technical scenarios on JustCharts: https://justcharts.merlintrader.com/#BRKR
0 replies